JENNIFER TERRIEN: Open Payments
NPI 1043039407 · SHAWNEE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 32 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $55 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $175 |
| Teva Pharmaceuticals USA, Inc. | 10 | $141 |
| E.R. Squibb & Sons, L.L.C. | 3 | $99 |
| Alkermes, Inc. | 4 | $78 |
| Almatica Pharma LLC | 3 | $64 |
| ABBVIE INC. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: INGREZZA, AUSTEDO XR, COBENFY, ARISTADA, LOREEV XR, VRAYLAR, SPRAVATO, Auvelity.
Industry payments across KS — which companies pay providers there.
